Cell-free expression of the APP transmembrane fragments with Alzheimer's disease mutations using algal amino acid mixture for structural NMR studies
- 1 July 2016
- journal article
- Published by Elsevier in Protein Expression and Purification
- Vol. 123, 105-111
Abstract
No abstract availableKeywords
Funding Information
- RFBR (14-04-01603-а)
- Russian Academy of Science Program
- RFBR (14-04-31763-mol_a, SP-1856.2015.4)
This publication has 23 references indexed in Scilit:
- Advances in NMR structures of integral membrane proteinsCurrent Opinion in Structural Biology, 2013
- Cell-free Expressed Bacteriorhodopsin in Different Soluble Membrane Mimetics: Biophysical Properties and NMR AccessibilityStructure, 2013
- Optimized Phospholipid Bilayer Nanodiscs Facilitate High-Resolution Structure Determination of Membrane ProteinsJournal of the American Chemical Society, 2013
- Expression screening of membrane proteins with cell-free protein synthesisProtein Expression and Purification, 2012
- γ-Secretase Catalyzes Sequential Cleavages of the AβPP Transmembrane DomainJournal of Alzheimer’s Disease, 2009
- Amyloidogenic Processing but Not Amyloid Precursor Protein (APP) Intracellular C-terminal Domain Production Requires a Precisely Oriented APP Dimer Assembled by Transmembrane GXXXG MotifsJournal of Biological Chemistry, 2008
- Why is the amyloid beta peptide of Alzheimer's disease neurotoxic?Dalton Transactions, 2008
- Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutantsBMC Neuroscience, 2008
- GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Aβ42The EMBO Journal, 2007
- A Continuous Cell-Free Translation System Capable of Producing Polypeptides in High YieldScience, 1988